ArticleCureus2025
Utility of Radiofrequency Echographic Multi-spectrometry in Evaluating Bone Health in Patients With Spondylarthritis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOsteoporosis, a condition characterized by reduced bone strength and increased fracture risk, frequently coexists with spondyloarthritis (SpA), an inflammatory rheumatic disease. Dual-energy X-ray absorptiometry (DXA), the gold standard for diagnosing osteoporosis, faces limitations in SpA patients due to spinal deformities and calcifications. Some studies have shown overestimation of BMD values, especially in individuals with syndesmophytic bridges and coexistent mechanical modifications such as osteophytes and discopathic lesions. MATERIALS AND
methodsA cross-sectional study was performed to compare the results of bone mineral density (BMD) lumbar spine evaluations performed with Radiofrequency Echographic Multi-spectrometry (REMS) between a control group and a group of patients recently diagnosed with axial spondyloarthritis (axSpA) who did not follow any specific treatment. All study participants were informed about the objectives, examinations performed, and the use of anonymous data in databases to conduct statistical analyses and publish findings in reference medical scientific journals.
resultsThe ratio between male and female participants differed between the study groups. No significant differences were observed between the control and SpA groups, in both female and male subjects, with regard to BMD values. When factoring in the age of the patients, it was observed that the mean age of the control group was 55.53 years, while that of the SpA group was 36.96 years. This suggests that the BMD values of younger SpA patients were equivalent to those of older individuals in the control group.
conclusionREMS is a useful tool for evaluating BMD both in the general population and in SpA patients. Furthermore, the lack of any statistically significant correlation between the control and SpA groups confirms that the rheumatic disease influences lumbar bone mineralization. Also, similar BMD values were observed between the groups, despite significantly different mean ages, supporting the conclusion that bone degradation appears early in the evolution of SpA and can be correctly identified using REMS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.